Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells.
暂无分享,去创建一个
M. Chiron | J. Jaffrezou | G. Laurent | H. Grandjean | T. Levade | E. Kuhlein | O. Thurneyssen | D. Carrière | J. Jaffrézou | D. Carrière
[1] I. Pastan,et al. Enhancement of the activity of immunotoxins by analogues of verapamil. , 1989, Cancer research.
[2] S. Ramakrishnan,et al. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds. , 1989, Cancer research.
[3] G. Pietersz,et al. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity. , 1988, Cancer research.
[4] J. Roth,et al. Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice. , 1988, Cancer research.
[5] P. Ghosh,et al. Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells. , 1987, The Journal of biological chemistry.
[6] P. Casellas,et al. Kinetics of cytotoxicity induced by immunotoxins. Enhancement by lysosomotropic amines and carboxylic ionophores. , 1984, The Journal of biological chemistry.
[7] J. Schwartz,et al. Synthesis and cardiovascular activity of a new series of cyclohexylaralkylamine derivatives related to perhexiline. , 1982, Journal of medicinal chemistry.
[8] I. Royston,et al. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. , 1980, Journal of immunology.
[9] Nicholas Bodor,et al. Designing safer drugs based on the soft drug approach , 1982 .